Norton Rose Fulbright appoints Davis as US Head of Life Sciences and Healthcare

United States Press release - People January 26, 2022

Global law firm Norton Rose Fulbright today announced the appointment of Dallas litigation partner D’Lesli Davis as its US Head of Life Sciences and Healthcare.

Davis’ practice focuses on the representation of pharmaceutical and medical device clients in high-stakes litigation in state and federal courts across the country, in MDLs and consolidated proceedings, governmental actions, commercial, economic loss and product liability matters.

Jeff Cody, Norton Rose Fulbright’s US Managing Partner, said:

“D’Lesli has achieved great success in notable pharmaceutical and medical device litigation. Her experience gives her perspective that will shape her leadership of the healthcare and life sciences team. I am thrilled to have D’Lesli guide the firm’s efforts in this ever-changing industry.”

Davis, who The Legal 500 United States lists as a recommended lawyer for healthcare and life sciences, said:

“The life sciences and healthcare sector is a dynamic and growing industry, with companies facing a complex range of legal and market challenges every day. I am excited to lead our firm’s talented healthcare and life sciences lawyers with our consistent focus on client service, thought leadership and creative problem-solving.”

Licensed in Texas, New York and Tennessee, Davis received her law degree with honors from the University of Texas Law School and a bachelor of business administration in accounting from Baylor University.

Contact

Head of Life Sciences and Healthcare, US and Co-Head of Product Liability and Consumer Disputes, US